TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive NCI To Lose 382 Cancer FTEs; DCE Board Gets Response From Sullivan, But No Promises July 21, 1989